Thursday, November 17, 2011
Print Current Session:
|
|
Thursday
SESSION 12:
METASTATIC LIVER DISEASE
Moderators:Daniel Y. Sze, MD, PhD / David C. Madoff, MD
|
|
SESSION 12 SCHEDULE | |
1:00 PM - 1:10 PM | Imaging Strategies To Assess Extent Of Disease And Results Of Therapy |
Presenter(s):Jean Francois H. Geschwind, MD | |
1:10 PM - 1:20 PM | Systemic And Neoadjuvant Therapy For Colorectal Disease |
Presenter(s):Andreas Kaubisch, MD | |
1:20 PM - 1:20 PM | Debate: TACE Is Best For Colorectal Metastases To The Liver |
Presenter(s):Michael C. Soulen, MD | |
1:30 PM - 1:40 PM | Debate: y-90 Should Be The Gold Standard For Colorectal Metastatic Liver Disease |
Presenter(s):Matthew S. Johnson, MD | |
1:40 PM - 1:50 PM | Evolution Of A New Treatment Modality For Metastatic Liver Cancer From Major Surgery To Percutaneous Intervention |
Presenter(s):Steven K. Libutti, MD | |
1:50 PM - 2:00 PM | Chemoperfusion For Metastatic Liver Disease |
Presenter(s):Bradford Wood, MD | |
2:00 PM - 2:10 PM | When Is Surgery Indicated For Metastatic Liver Lesions? |
Presenter(s):Milan Kinkhabwala, MD | |
2:10 PM - 2:20 PM | Ablation Therapy Should Be Used In Combination With Other Therapies |
Presenter(s):Riccardo Lencioni, MD | |
2:20 PM - 2:30 PM | Management Of Neuroendocrine Tumors |
Presenter(s):Karen T. Brown, MD | |
2:30 PM - 2:40 PM | Chemoperfusion For Neuroendocrine Tumors: Early Results |
Presenter(s):Bradford Wood, MD | |
2:40 PM - 2:50 PM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 12 | |
previous | next |